5417 |
Non-hyperemic Pressure Indices: Pros & Cons |
Javier Escaned |
Apr. 08. 22 |
5416 |
FFR, It\'s Standard |
Jung-Min Ahn |
Apr. 08. 22 |
5415 |
Moderators\' Introductory Keynote: Invasive vs Non-invasive FFR |
Nico Pijls |
Apr. 08. 22 |
5414 |
FFR-Guided PCI for Multivessel CAD in 2022 |
William F. Fearon |
Apr. 08. 22 |
5413 |
Moderators\' Introductory Keynote: Revascularization after FAME 3- How Will We Decide? |
Spencer B. King III |
Apr. 08. 22 |
5412 |
Racial Disparities in TAVR: Similarities and Differences |
Duk-Woo Park |
Apr. 08. 22 |
5411 |
The UPSTREAM Management of Aortic Stenosis |
Martin Bert Leon |
Apr. 08. 22 |
5410 |
CABG Helps People Live Longer |
S. Christopher Malaisrie |
Apr. 08. 22 |
5409 |
Which Patients with Stable CAD Benefit from PCI in the Post-ISCHEMIA Era? |
Gregg W. Stone |
Apr. 08. 22 |
5408 |
OMT Is Always the Default Choice |
David J. Maron |
Apr. 08. 22 |